Shows
Driving the Business of ScienceBeyond Compliance: Building Brands in Regulated MarketsIn this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, and Roy Strunin, Director of Marketing at BrandUp Strategy, discuss the intersection of business, science, and marketing in the pharmaceutical, biotech, and medical device industries. Keith highlights the collaboration between Court Square Group, a managed service firm specializing in IT infrastructure for life science organizations, and BrandUp Strategy, a full-service marketing agency supporting life science service providers. Roy shares his background in life science marketing and the founding of BrandUp Strategy. Together, they explore the differences between technology...
2025-12-1926 min
Driving the Business of ScienceTranslational Science in Action. Driving Innovation.In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, interviews Joseph Jerry, Ph.D., a researcher at UMass Amherst and Science Director of Pioneer Valley Life Sciences Institute (PVLSI). Dr. Jerry explains PVLSI's role in translational research, particularly in breast cancer, and the creation of the breast research registry and HistoSpring. They discuss the importance of diverse patient populations, the use of human tissues for research, and the potential of organoids. The conversation highlights the collaboration between academia, healthcare, and industry in advancing scientific research.
2025-11-1828 min
Driving the Business of ScienceEffectively Selling Science. Overcoming Barriers to Growth.In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, and Dave Kwajewski, Executive Director of Business Development at Corealis Pharma, discuss the challenges and strategies in selling science. Dave, with 22.5 years in sales, emphasizes the importance of understanding scientific processes and the evolution of sales techniques, from traditional trade shows to AI-driven interactions. He highlights the need for companies to focus on their strengths, especially in early drug development, and advises leaders to hire smartly and understand market realities. Keith and David agree on the value of n...
2025-11-0528 min
Driving the Business of ScienceAI in Clinical Trials. A Scientist's Perspective.Keith Parent, CEO of Court Square Group, discusses the intersection of science and business in drug development with Dr. Joseph Geraci, Founder, Chief Scientific and Technical Officer of NetraMark. Dr. Geraci, with a background in mathematics and AI, focuses on understanding patient populations and improving clinical trials. He explains how NetraMark's AI technology can analyze small, complex data sets to identify treatment and placebo responder subpopulations and improve drug efficacy. Dr. Geraci emphasizes the potential of adaptive trials and the importance of personalized medicine. He predicts the future of AI in clinical trials will involve modular AI systems integrating...
2025-10-2325 min
Driving the Business of SciencePharma Start-ups. Perspectives from a Serial Entrepreneur.In this episode of the Driving the Business of Science podcast, hosted by Keith Parent, CEO of Court Square Group, guest Mark Connell, Co-Founder and President of SLBST Pharma, discusses the company’s mission to repurpose hydroxychloroquine to treat endometriosis, a condition affecting 7 million American women. Despite limited current therapies, SLBST Pharma aims to leverage the drug’s proven efficacy in reducing lesions by 60%. Challenges include navigating the complexities of drug development, fundraising, and staying agile amidst setbacks. Connell emphasizes the importance of tenacity, community engagement, and the ultimate goal of alleviating pain and improving lives.
2025-10-0929 min
Driving the Business of ScienceEstablishing Worldwide Networks for Pharmaceutical CompaniesIn this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, and guest Michael Joseph, CEO of Technium, discuss their collaboration on global networks for the life science industry. Technium specializes in connecting data from the edge to the cloud, offering secure network services and leveraging AI advancements. Their recent projects include assisting Moderna with their global network during the COVID pandemic and designing a network for Frontier Scientific Solutions to revolutionize the clinical supply chain. Both firms emphasized the importance of security, reliability, and the collegial approach to...
2025-09-2627 min
Driving the Business of ScienceFrom Small Introductions to Global Projects: A Networking Approach to Life Sciences PartnershipsKeith Parent, CEO of Court Square Group, discusses the complexities of the life science industry and introduces Chris Matheus from the Global Life Science Alliance (GLSA). Chris, with 30 years in clinical research, co-founded GLSA to connect smaller companies with business development opportunities and experts. The conversation emphasizes the importance of collaboration and networking, highlighting GLSA's role in facilitating connections for regulatory consulting, pre-clinical, and clinical trial management, and innovative solutions such as AI. Chris and Keith also talk about "Friends of Chris Matheus" (FOCM), a networking club he founded to foster industry connections. The conversation underscores the need for...
2025-09-1221 min
Driving the Business of ScienceThe Evolving World of Data Management in Life ScienceIn this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, discusses with Mario Perkins, President of Triam Ltd, the intersection of IT infrastructure and data management in the life sciences. Triam specializes in data management and analytics, particularly in healthcare and life sciences, and has recently partnered with Court Square. They discuss the shift from legacy systems like SAS to open-source tools like Python and R, disruptive technologies like Altair SLC and RapidMiner that can bridge and enhance this shift, the importance of data quality, and the benefits of...
2025-08-2528 min
Driving the Business of ScienceMaking Connections Internationally. How Does it Work?In this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, interviews Christa Bleyleben, Managing Partner at MassGlobal Partners. Christa's firm helps international early and growth-stage companies navigate the U.S. market, providing programs for C-level executives to learn business practices, networking, and cultural differences. They work with companies from various sectors, including life sciences, robotics, and AI, and have supported firms from countries like Korea, Japan, and Northern Ireland. Christa emphasizes the importance of understanding U.S. market dynamics, the rigorous due diligence process for investors, and the value...
2025-08-1327 min
Driving the Business of ScienceEngaging with Key Opinion Leaders (KOLs)In this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, speaks with Arielle Smith, President of Life Sciences at Event Cadence about their event technology platform which supports medical conferences and Key Opinion Leader (KOL) engagement. They discuss the importance of in-person interactions and the evolving landscape of HCP (Healthcare Provider) engagement. Event Cadence's Ensemble software facilitates omni-channel engagement, adapting to different company needs, from small startups to large pharma companies. The conversation emphasizes the value of personal connections and the future potential of KOLs reaching out to pharma...
2025-07-2626 min
Driving the Business of ScienceUnlocking Value: Why Latin America is the Strategic Choice for Phase 1 TrialsIn this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, interviews Sara Tylosky, CEO of Farmacon Global, about the Latin American market for clinical trials. Farmacon Global, a strategic partner with a network of physicians, focuses on rare diseases, oncology, and immunology in Latin America. Sara highlights the region's diversity, cost savings, and fast recruitment, noting that Latin America represents 0.7% of global phase 1 studies but has a population of more than 660 million and 30+ qualified sites. She addresses misconceptions about slow recruitment and regulatory issues, emphasizing the region's alignment with...
2025-07-1823 min
Driving the Business of ScienceMental Health Across the Life Science SpectrumIn this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, hosts Samantha Trotman Burman to discuss mental health across the life science spectrum. Samantha, CEO and co-founder of StoryCatch Partners, shares her journey in mental health advocacy, driven by personal experiences and the need for better support and data collection. She emphasizes the importance of integrating mental and physical health data, using real-world examples like knee replacements and heart surgery. Samantha highlights the role of caregivers and the impact of mental health on them. She also discusses the company's...
2025-07-0225 min
Driving the Business of SciencePharmacovigilance Compliance for Small and Mid-sized SponsorsIn this episode of Driving the Business of Science, Keith Parent, CEO of Court Square Group discusses pharmacovigilance compliance for small and mid-sized sponsors with Betty Cory, President of Regxia. Betty explains that pharmacovigilance monitors drug safety in real-world use, often revealing unforeseen adverse effects. Small companies struggle with managing vast amounts of data, necessitating electronic systems. Betty emphasizes the importance of finding partners who understand small businesses' needs and can provide tailored solutions. Court Square Group's platform, RegDocs365™, is highlighted as a fit-for-purpose solution. Betty also shares her background and the philosophy of Regxia, which focuses on...
2025-06-1720 min
Driving the Business of ScienceChallenges and Opportunities in AI ImplementationIn this episode of Driving the Business of Science, Keith Parent, CEO of Court Square Group, talks with Catherine Lunardi, CEO of GENAIZ, about the challenges and opportunities of implementing Artificial Intelligence (AI) in life science companies. Catherine explains her company's Intelligent Automation solutions, particularly their data orchestration platform. They discuss their partnership, which began at an economic development forum in Massachusetts. Catherine shares her background in pharmaceuticals and the inspiration behind GENAIZ, emphasizing the importance of AI in streamlining data management. They highlight successful projects involving a cross-referencing tool for large document volumes and introduce GENAIZ's...
2025-06-0425 min
Driving the Business of ScienceDe-Risking the Early Phase Clinical Trial Supply ChainKeith Parent, CEO of Court Square Group, discusses De-Risking the Early Phase Clinical Trial Supply Chain with Jim Kernan, CEO of PRONAV Clinical, a 40-year veteran of the pharmaceutical industry. Their conversation focuses on early-phase clinical supply chains, highlighting the shift from linear to multi-nodal supply chains in biotech. Jim explains the role of the Qualified Person (QP) in ensuring GMP compliance and data management, emphasizing the importance of secure data handling. They also discuss the complexities of cold chain logistics, particularly the challenges of maintaining -80°C temperatures for biologics, and the validation of labeling processes f...
2025-05-1926 min
Driving the Business of ScienceElevating Life Science Meetings & EventsIn this episode of Driving the Business of Science, Elevating Life Science Meetings & Events, Keith Parent, CEO of Court Square Group, discusses with Sam Ali, co-founder of Precision Evolution Global, the importance of attending and participating in industry events. Effective industry events aimed at decision-makers in pharma, biotech, and CROs, covering clinical trials, drug discovery, and pharma supply chains, connect key stakeholders who might otherwise struggle to find each other. As Sam explains, traditional conference models often fail to facilitate meaningful connections that extend beyond the event itself. Their company was founded specifically to address this gap b...
2025-05-0624 min
Driving the Business of ScienceThe Importance of QualityKeith Parent, CEO of Court Square Group, discusses the business aspects of drug development with James Blackwell, Ph.D., MBA, President of Windshire Group. They explore the importance of quality in life science, emphasizing the need for a holistic approach beyond compliance. Blackwell highlights the significance of modality-agnostic strategies, the impact of AI on efficiency, and the necessity of a simple yet effective quality system. He shares insights on managing compliance, the importance of senior leadership, and the potential cost savings from effective quality systems, citing an example where a challenging, but well-executed investigation saved AbbVie ~$8.5 billion by avoiding...
2025-04-2227 min
Driving the Business of ScienceStakeholder Engagement: CROs, Vendors, and SitesIn this episode of Driving the Business of Science, Stakeholder Engagement: CROs, Vendors, and Sites, Keith Parent, CEO of Court Square Group, discusses the complexities of stakeholder engagement in the life science industry with Kimberly Guedes, VP of Clinical Operations at Intensity Pharmaceuticals. Keith and Kim explore the challenges facing small biotechs when partnering with large CROs, emphasizing the need for fit for purpose, cost-effective solutions like RegDocs365™. Kim discusses the importance of selecting the right CROs and vendors, especially for niche therapeutic areas like CNS. Keith and Kim also discuss the high costs of clinical trials, th...
2025-04-0726 min
Driving the Business of ScienceWomen's Health and the Start-up CommunityKeith Parent, CEO of Court Square Group, hosts Shelley Amster on the "Driving the Business of Science" podcast. Shelley, with over 45 years in women's health, discusses her extensive experience in mentoring startups and connecting them with strategic partners and investors. She highlights the challenges faced by small biotech companies, particularly in women's health, and the importance of mentorship and collaboration. Shelley shares perspectives from her role as an Entrepreneur in Residence, helping Israeli companies establish a presence in the U.S. She emphasizes the need for startups to understand the business aspects of their technology and the value of...
2025-03-2824 min
Driving the Business of ScienceCMC: What Do You Mean?Keith Parent, CEO of Court Square Group, discusses with Kevin Bittorf, a partner at SCxCMC Solutions, about the role of CMC (Chemistry, Manufacturing, and Controls) in the pharmaceutical industry. Kevin explains that CMC involves the science and business of manufacturing, emphasizing the importance of continuous improvement to reduce costs and enhance quality. SCxCMC, founded two years ago, provides consulting services to small and medium-sized companies, integrating expertise in pharmaceutical development, process chemistry, formulation development, regulatory affairs, quality assurance, supply chain, and packaging. Kevin highlights the significance of AI in predicting manufacturing issues and the benefits of continuous manufacturing over...
2025-03-1525 min
Driving the Business of ScienceDeveloping Your AI StrategyDiscover how artificial intelligence is transforming the life sciences industry in this insightful episode of the Driving the Business Science Podcast. Host Keith Parent, CEO of Court Square Group and RegDocs365, is joined by Bryan Reynolds, CEO of Docxonomy, to discuss practical strategies for developing and implementing AI in organizations of all sizes. Drawing on decades of experience in unstructured data management and AI, Bryan shares actionable insights into overcoming common challenges, such as protecting sensitive corporate data, streamlining processes, and maximizing ROI.This conversation highlights how AI can revolutionize workflows, accelerate drug development timelines, and reduce manual...
2025-02-1123 min
Driving the Business of ScienceOvercoming Challenges in Selecting CROs and Clinical Trial VendorsKeith Parent, CEO of Court Square Group and RegDocs365, discusses the importance of vendor management in life science with Kalyan Obalampalli (KO), CEO of ClinAI. KO shares his experience in managing $100 million in vendor contracts and the challenges of using Excel for RFPs and vendor comparisons. He highlights the benefits of ClinAI's platform, which streamlines vendor selection and management, providing analytics and data-driven decision-making. KO emphasizes the need for fit-for-purpose vendor selection, the importance of clear templates, and the potential of AI in predicting costs and ensuring fair vendor payments.Driving the Business of Science...
2025-01-2922 min